# OMEROS CORP > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:262be438-8168-4cf8-8daf-199d474cff1d | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/omeros-corp | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 15 | | Claims under review | 1 | | Evidence records | 12 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-18T07:12:02.527648+00:00 | | Last reviewed | 2026-10-18T07:12:02.527648+00:00 | ## Identity - Legal name: OMEROS CORP - Display name: OMEROS CORP ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-18T07:12:02.527648+00:00 | | Completeness | 0.318 | | Record Quality | 0.829 | | Directors | 0 | | Committees | 0 | | Governance events | 11 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | NOT_REVIEWED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Executive leadership - Andreas Grauer, M.D.: Vice President, Chief Medical Officer. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:5 - Catherine A. Melfi, Ph.D.: Vice President, Regulatory Affairs Quality Systems and Chief Regulatory Officer. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:6 - David J. Borges: Vice President, Finance, Chief Accounting Officer and Treasurer [CAO]. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:7 - David W. Ghesquiere: Vice President, Chief Business Development Officer. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:8 - George Mclean Milne Jr., Ph.D.: Vice President, Science and Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:9 - Giovanni Caforio, M.D.: President, Chief Executive Officer and Chairman of the Board of Directors [CEO]. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:10 - J. Steven Whitaker, M.D., J.D.: Vice President, Clinical Development. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:11 - Mariana N. Dimitrova, Ph.D.: Vice President, Chemistry, Manufacturing and Controls. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:12 - Nadia Dac: Vice President, Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:13 - Paul S. Williams: Vice President, Human Resources. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:14 - Peter B. Cancelmo, J.D.: Vice President, General Counsel and Secretary [GC]. Status: current. claim_id=alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:15 ## Governance events - EXECUTIVE_APPOINTED: Andreas Grauer, M.D. executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:1lqroe01fw0l7i - EXECUTIVE_APPOINTED: Catherine A. Melfi, Ph.D. executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:1jb5uifv9zdfx - EXECUTIVE_APPOINTED: David J. Borges executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:tmup8m16bwyv0 - EXECUTIVE_APPOINTED: David W. Ghesquiere executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:1i01tvzfr3flx - EXECUTIVE_APPOINTED: George Mclean Milne Jr., Ph.D. executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:ebd5gu1gd2xo4 - CEO_CHANGED: Giovanni Caforio, M.D. executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:7s588s16cxzcu - EXECUTIVE_APPOINTED: J. Steven Whitaker, M.D., J.D. executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:1ufaeg1tug0po - EXECUTIVE_APPOINTED: Mariana N. Dimitrova, Ph.D. executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:u2smhs1lnekd8 - EXECUTIVE_APPOINTED: Nadia Dac executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:vcfbbb18pfjr - EXECUTIVE_APPOINTED: Paul S. Williams executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:1atfbsb19cj517 - GC_CHANGED: Peter B. Cancelmo, J.D. executive of OMEROS CORP, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:qia9zt1heyebr ## Scoped resources - `alpha://company/omeros-corp` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record - `alpha://company/omeros-corp/identity` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=identity - `alpha://company/omeros-corp/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=corporate-structure - `alpha://company/omeros-corp/board` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=board - `alpha://company/omeros-corp/committees` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=committees - `alpha://company/omeros-corp/leadership` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=leadership - `alpha://company/omeros-corp/ownership` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=ownership - `alpha://company/omeros-corp/financials` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=financials - `alpha://company/omeros-corp/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=capital-structure - `alpha://company/omeros-corp/compensation` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=compensation - `alpha://company/omeros-corp/governance` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=governance - `alpha://company/omeros-corp/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=shareholder-governance - `alpha://company/omeros-corp/audit` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=audit - `alpha://company/omeros-corp/legal` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=legal - `alpha://company/omeros-corp/risk` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=risk - `alpha://company/omeros-corp/cyber` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=cyber - `alpha://company/omeros-corp/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=ai-governance - `alpha://company/omeros-corp/agents` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=agents - `alpha://company/omeros-corp/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=ecosystem - `alpha://company/omeros-corp/events` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=events - `alpha://company/omeros-corp/relationships` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=relationships - `alpha://company/omeros-corp/assessments` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=assessments - `alpha://company/omeros-corp/evidence` (contract): https://registry.alpha.ac/api/public/companies/omeros-corp?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Andreas Grauer, M.D.: Vice President, Chief Medical Officer. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:5. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:72a76c429da955d685fbf96da0ab218ff8042248a250c58afe1411f86cc4a998. - Catherine A. Melfi, Ph.D.: Vice President, Regulatory Affairs Quality Systems and Chief Regulatory Officer. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:6. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7832ec665ba1e1e04a2f557e1132751dc9924a2f12da220357b70211bb318876. - David J. Borges: Vice President, Finance, Chief Accounting Officer and Treasurer. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:7. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:32f88643cdccc47290855016ed7ce5722b4140c371e580e064f0f67cbcdf1c17. - David W. Ghesquiere: Vice President, Chief Business Development Officer. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:8. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:88ffbfe132e00c53455748a71a637c9c3a341291f4c82ee46d2a0129574e8d00. - George Mclean Milne Jr., Ph.D.: Vice President, Science and Chief Scientific Officer. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:9. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9da6654d111ac1a8216906a6674e30a10e04a991a46093378b18693299ccb7a7. - Giovanni Caforio, M.D.: President, Chief Executive Officer and Chairman of the Board of Directors. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:10. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e861fb22652729be540f3d63e90f50624868ba7de61eaaf7e12f9b834f72947. - J. Steven Whitaker, M.D., J.D.: Vice President, Clinical Development. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:11. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:69958cb71c8a37d22eeb752e5ea12d77fb2ba56307f19b4f3596d0c399fb5c6a. - Mariana N. Dimitrova, Ph.D.: Vice President, Chemistry, Manufacturing and Controls. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:12. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6cc420eb1036cfad56ae6b04576b6eb5440d3c19916d20d17e71c5dd36f58c33. - Nadia Dac: Vice President, Chief Commercial Officer. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:13. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:14f2ea40b4c834bca50607058cc1702b7bbff63467a4dd8047f801c8f784593a. - Paul S. Williams: Vice President, Human Resources. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:14. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:91a201f8e68ff0bcfc3cdcd26be6f050c820b0622ee6559225341e96ec045182. - Peter B. Cancelmo, J.D.: Vice President, General Counsel and Secretary. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:leadership_role:15. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c2012aea2293e3467d43e2546155a00847f7a02daaeea22c57e42ee06809d76. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - NOT_ASSERTED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - OMEROS CORP. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:aca9d58c60a101f4ab6f0e2102173b059e87a2b54dc02a60c70efd074abb8cd9. ## Entity Status - Public listing published. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:aca9d58c60a101f4ab6f0e2102173b059e87a2b54dc02a60c70efd074abb8cd9. ## Published Fact - US. Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:aca9d58c60a101f4ab6f0e2102173b059e87a2b54dc02a60c70efd074abb8cd9. ## Security Listing - OMER (NASDAQ). Claim: alpha:claim:company:262be438-8168-4cf8-8daf-199d474cff1d:security_listing:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:aca9d58c60a101f4ab6f0e2102173b059e87a2b54dc02a60c70efd074abb8cd9. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | NOT_ASSERTED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:aca9d58c60a101f4ab6f0e2102173b059e87a2b54dc02a60c70efd074abb8cd9: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/omeros-corp). - alpha:projection-evidence:document:72a76c429da955d685fbf96da0ab218ff8042248a250c58afe1411f86cc4a998: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:7832ec665ba1e1e04a2f557e1132751dc9924a2f12da220357b70211bb318876: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:32f88643cdccc47290855016ed7ce5722b4140c371e580e064f0f67cbcdf1c17: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:88ffbfe132e00c53455748a71a637c9c3a341291f4c82ee46d2a0129574e8d00: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:9da6654d111ac1a8216906a6674e30a10e04a991a46093378b18693299ccb7a7: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:7e861fb22652729be540f3d63e90f50624868ba7de61eaaf7e12f9b834f72947: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:69958cb71c8a37d22eeb752e5ea12d77fb2ba56307f19b4f3596d0c399fb5c6a: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:6cc420eb1036cfad56ae6b04576b6eb5440d3c19916d20d17e71c5dd36f58c33: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:14f2ea40b4c834bca50607058cc1702b7bbff63467a4dd8047f801c8f784593a: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:91a201f8e68ff0bcfc3cdcd26be6f050c820b0622ee6559225341e96ec045182: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). - alpha:projection-evidence:document:9c2012aea2293e3467d43e2546155a00847f7a02daaeea22c57e42ee06809d76: [OMER 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/omeros-corp) - [Public Markdown](https://registry.alpha.ac/companies/omeros-corp.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/omeros-corp?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/omeros-corp?format=jsonld) - MCP resource: `alpha://companies/omeros-corp` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-18T15:51:21.379029+00:00; recorded 2026-10-18T15:51:21.379029+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.